Atlas Trials

Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT

Clinical trial NCT00236678 · TERMINATED

Trial details

NCT number
NCT00236678
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
AnemiaRheumatoid Arthritis
Start date
2004-07-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.